Microbix Financial Statements From 2010 to 2025

MBX Stock  CAD 0.28  0.01  3.45%   
Microbix Biosystems' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Microbix Biosystems' valuation are provided below:
Gross Profit
13.1 M
Profit Margin
0.0689
Market Capitalization
40.2 M
Enterprise Value Revenue
1.3646
Revenue
22.7 M
We have found one hundred twenty available fundamental ratios for Microbix Biosystems, which can be analyzed and compared to other ratios and to its peers in the industry. Self-guided Investors are advised to check Microbix Biosystems' last-minute fundamentals against the trend between 2010 and 2025 to make sure the company can sustain itself down the road. As of the 12th of August 2025, Market Cap is likely to drop to about 22.7 M. In addition to that, Enterprise Value is likely to drop to about 24.4 M

Microbix Biosystems Total Revenue

30.66 Million

Check Microbix Biosystems financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Microbix Biosystems' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 M, Interest Expense of 536.4 K or Selling General Administrative of 10.7 M, as well as many indicators such as Price To Sales Ratio of 1.97, Dividend Yield of 1.97 or PTB Ratio of 1.77. Microbix financial statements analysis is a perfect complement when working with Microbix Biosystems Valuation or Volatility modules.
  
This module can also supplement various Microbix Biosystems Technical models . Check out the analysis of Microbix Biosystems Correlation against competitors.

Microbix Biosystems Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets46 M43.8 M25.5 M
Slightly volatile
Short and Long Term Debt Total4.5 M7.6 M6.2 M
Slightly volatile
Total Current Liabilities2.7 M3.9 M3.7 M
Slightly volatile
Total Stockholder Equity34.2 M32.5 M16.4 M
Slightly volatile
Property Plant And Equipment NetM11.1 M8.2 M
Slightly volatile
Accounts Payable1.5 M2.4 M1.8 M
Slightly volatile
Cash15.7 M14.9 M5.4 M
Slightly volatile
Non Current Assets Total9.2 M15.9 M12.5 M
Pretty Stable
Cash And Short Term Investments15.7 M14.9 M5.4 M
Slightly volatile
Net ReceivablesM4.8 M2.6 M
Slightly volatile
Common Stock Shares Outstanding162.4 M154.7 M103.5 M
Slightly volatile
Liabilities And Stockholders Equity46 M43.8 M25.5 M
Slightly volatile
Inventory7.8 M7.4 M4.1 M
Slightly volatile
Other Current Assets777 K740 K378.2 K
Slightly volatile
Other Stockholder Equity2.5 M2.6 M7.4 M
Very volatile
Total Liabilities6.7 M11.3 M8.8 M
Slightly volatile
Property Plant And Equipment Gross23.2 M22.1 M12 M
Slightly volatile
Total Current Assets29.3 M27.9 M12.5 M
Slightly volatile
Non Current Liabilities Total4.1 M7.4 M5.2 M
Slightly volatile
Intangible Assets3.6 M4.9 M3.9 M
Very volatile
Common Stock Total Equity31.8 M40.7 M31.6 M
Slightly volatile
Common Stock37 M56 M36 M
Slightly volatile
Other Liabilities330.1 K371.4 K404.9 K
Slightly volatile
Net Tangible Assets28.3 M27 M13 M
Slightly volatile
Long Term Debt5.3 M6.4 MM
Pretty Stable
Short and Long Term Debt95 K100 K1.1 M
Slightly volatile
Property Plant Equipment7.4 M8.7 MM
Pretty Stable
Long Term Debt Total5.8 M7.1 M5.5 M
Slightly volatile
Capital Surpluse9.6 M12.3 M7.9 M
Slightly volatile
Capital Lease Obligations609.4 K804.7 K404 K
Slightly volatile
Net Invested Capital25.8 M39.1 M24.2 M
Slightly volatile
Capital Stock46.3 M56 M39.6 M
Slightly volatile
Non Current Liabilities Other219.3 K224.6 K286 K
Slightly volatile

Microbix Biosystems Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization1.4 M1.3 M727.9 K
Slightly volatile
Selling General Administrative10.7 M10.2 M4.6 M
Slightly volatile
Total Revenue30.7 M29.2 M14.4 M
Slightly volatile
Gross Profit18.6 M17.7 M7.9 M
Slightly volatile
Other Operating Expenses23.2 M22.1 M12.6 M
Slightly volatile
Research Development2.6 M2.4 M1.3 M
Slightly volatile
Cost Of Revenue12.1 M11.5 M6.4 M
Slightly volatile
Total Operating Expenses25.9 M24.7 M8.8 M
Slightly volatile
Selling And Marketing Expenses784.7 K1.3 M965.1 K
Pretty Stable
Reconciled Depreciation974.5 K1.9 M811.1 K
Slightly volatile

Microbix Biosystems Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow14 M13.3 MM
Slightly volatile
Depreciation1.9 M1.9 M823.5 K
Slightly volatile
Capital Expenditures1.1 M2.2 M1.5 M
Very volatile
End Period Cash Flow15.7 M14.9 M5.4 M
Slightly volatile
Stock Based Compensation436.9 K821.4 K421.1 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.972.072.9487
Slightly volatile
Dividend Yield1.973.093.2238
Very volatile
PTB Ratio1.771.862.5581
Slightly volatile
Days Sales Outstanding82.5969.2471.7902
Pretty Stable
Book Value Per Share0.0960.190.1481
Very volatile
Average Payables992 K1.5 M1.6 M
Very volatile
Stock Based Compensation To Revenue0.03490.03230.0329
Pretty Stable
Capex To Depreciation1.871.062.6634
Slightly volatile
PB Ratio1.771.862.5581
Slightly volatile
EV To Sales1.691.783.1014
Slightly volatile
Inventory Turnover2.181.781.7542
Pretty Stable
Days Of Inventory On Hand286271343
Slightly volatile
Payables Turnover2.13.382.9841
Slightly volatile
Sales General And Administrative To Revenue0.360.390.3241
Very volatile
Average Inventory5.2 MM3.7 M
Slightly volatile
Research And Ddevelopement To Revenue0.09140.09630.1036
Slightly volatile
Capex To Revenue0.150.08630.1335
Pretty Stable
Cash Per Share0.110.09480.0496
Slightly volatile
Days Payables Outstanding178112142
Slightly volatile
Intangibles To Total Assets0.210.130.1803
Slightly volatile
Current Ratio6.756.433.5892
Slightly volatile
Tangible Book Value Per Share0.170.160.1129
Slightly volatile
Receivables Turnover4.35.465.4235
Pretty Stable
Graham Number0.330.310.1665
Slightly volatile
Shareholders Equity Per Share0.0960.190.1481
Very volatile
Debt To Equity0.190.20.53
Slightly volatile
Capex Per Share0.01260.01390.0157
Pretty Stable
Average Receivables3.4 M3.3 M2.3 M
Slightly volatile
Revenue Per Share0.0880.170.1253
Slightly volatile
Interest Debt Per Share0.0510.04820.0737
Slightly volatile
Debt To Assets0.220.150.2765
Slightly volatile
Operating Cycle376341324
Very volatile
Price Book Value Ratio1.771.862.5581
Slightly volatile
Days Of Payables Outstanding178112142
Slightly volatile
Ebt Per Ebit1.50.852.6201
Pretty Stable
Company Equity Multiplier1.471.211.7513
Slightly volatile
Long Term Debt To Capitalization0.220.150.2702
Slightly volatile
Total Debt To Capitalization0.260.170.3188
Slightly volatile
Debt Equity Ratio0.190.20.53
Slightly volatile
Quick Ratio6.336.032.6828
Slightly volatile
Net Income Per E B T0.850.861.0663
Very volatile
Cash Ratio3.613.441.6657
Slightly volatile
Cash Conversion Cycle174229173
Slightly volatile
Days Of Inventory Outstanding286271343
Slightly volatile
Days Of Sales Outstanding82.5969.2471.7902
Pretty Stable
Price To Book Ratio1.771.862.5581
Slightly volatile
Fixed Asset Turnover1.963.041.77
Slightly volatile
Debt Ratio0.220.150.2765
Slightly volatile
Price Sales Ratio1.972.072.9487
Slightly volatile
Asset Turnover0.690.770.5505
Slightly volatile
Gross Profit Margin0.630.70.5532
Very volatile
Price Fair Value1.771.862.5581
Slightly volatile

Microbix Biosystems Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap22.7 M41.2 M33.2 M
Slightly volatile
Enterprise Value24.4 M35.3 M35.3 M
Slightly volatile

Microbix Fundamental Market Drivers

Forward Price Earnings17.2414
Cash And Short Term Investments13 M

About Microbix Biosystems Financial Statements

Microbix Biosystems investors utilize fundamental indicators, such as revenue or net income, to predict how Microbix Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue2.3 M2.4 M
Total Revenue29.2 M30.7 M
Cost Of Revenue11.5 M12.1 M
Stock Based Compensation To Revenue 0.03  0.03 
Sales General And Administrative To Revenue 0.39  0.36 
Research And Ddevelopement To Revenue 0.10  0.09 
Capex To Revenue 0.09  0.15 
Revenue Per Share 0.17  0.09 
Ebit Per Revenue 0.14  0.15 

Pair Trading with Microbix Biosystems

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Microbix Biosystems position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Microbix Biosystems will appreciate offsetting losses from the drop in the long position's value.

Moving against Microbix Stock

  0.78HR-UN HR Real Estate Earnings Call TomorrowPairCorr
  0.73GENM Generation Mining Earnings Call TomorrowPairCorr
  0.53TNO-H Terreno Resources CorpPairCorr
The ability to find closely correlated positions to Microbix Biosystems could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microbix Biosystems when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microbix Biosystems - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microbix Biosystems to buy it.
The correlation of Microbix Biosystems is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microbix Biosystems moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microbix Biosystems moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Microbix Biosystems can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Microbix Stock

Microbix Biosystems financial ratios help investors to determine whether Microbix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Microbix with respect to the benefits of owning Microbix Biosystems security.